These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32557822)

  • 1. Over 870 days of successful antibiotic suppression therapy for VRE-infected left ventricular assist device.
    Radcliffe C; Grant M
    J Card Surg; 2020 Jul; 35(7):1746-1748. PubMed ID: 32557822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium.
    Mueller SW; Kiser TH; Anderson TA; Neumann RT
    Ann Pharmacother; 2012 Dec; 46(12):e35. PubMed ID: 23232018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: case report and review of the literature.
    Levy DT; Steed ME; Rybak MJ; Guo Y; Gialanella P; Hanau L; Muggia V; Ostrowsky B
    Transpl Infect Dis; 2012 Oct; 14(5):E89-96. PubMed ID: 22931050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant gram-positive infections in patients with ventricular assist devices: the role of daptomycin.
    Beiras-Fernandez A; Kur F; Kiefer S; Sodian R; Schmoeckel M; Weis M; Reichart B; Weis F
    Transplant Proc; 2009; 41(6):2589-91. PubMed ID: 19715980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
    Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
    J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of vancomycin resistant Enterococcus faecium mediastinitis associated with left ventricular assist devices.
    Malani PN; Dyke DB; Pagani FD; Armstrong WS; Chenoweth CE
    Ann Thorac Surg; 2003 Nov; 76(5):1719-20. PubMed ID: 14602322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.
    Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chang SC
    Clin Microbiol Infect; 2016 Oct; 22(10):890.e1-890.e7. PubMed ID: 27475738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-resistant Enterococcus faecium osteoarthritis following Staphylococcus aureus hip infection.
    Pasticci MB; Baldelli F; Malincarne L; Mancini GB; Marroni M; Morosi S; Stagni G
    Orthopedics; 2005 Dec; 28(12):1457-8. PubMed ID: 16366086
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of vancomycin-resistant Enterococcus faecium pyelonephritis with daptomycin during pregnancy.
    Shea K; Hilburger E; Baroco A; Oldfield E
    Ann Pharmacother; 2008 May; 42(5):722-5. PubMed ID: 18349306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid in the treatment of vancomycin-resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate-use trial.
    El-Khoury J; Fishman JA
    Transpl Infect Dis; 2003 Sep; 5(3):121-5. PubMed ID: 14617299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Linezolid-resistant Enterococcus faecium: the first G2576T mutation in Turkey].
    Afşar I; Barış I; Sener AG; Köksal V; Demirci M
    Mikrobiyol Bul; 2012 Jul; 46(3):516-8. PubMed ID: 22951666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-center experience with infections due to daptomycin-nonsusceptible Enterococcus faecium in liver transplant recipients.
    Lewis JD; Enfield KB; Cox HL; Mathers AJ; Sifri CD
    Transpl Infect Dis; 2016 Jun; 18(3):341-53. PubMed ID: 26953719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.
    Kvirikadze N; Suseno M; Vescio T; Kaminer L; Singh K
    Scand J Infect Dis; 2006; 38(4):290-2. PubMed ID: 16709529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients.
    Lewis JD; Barros AJ; Sifri CD
    Transpl Infect Dis; 2018 Jun; 20(3):e12856. PubMed ID: 29427322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
    Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.
    Yim J; Smith JR; Rybak MJ
    Pharmacotherapy; 2017 May; 37(5):579-592. PubMed ID: 28273381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daptomycin in the treatment of prosthetic joint infection by Enterococcus faecalis: safety and efficacy of high-dose and prolonged therapy.
    Yuste JR; Quesada M; Díaz-Rada P; Del Pozo JL
    Int J Infect Dis; 2014 Oct; 27():65-6. PubMed ID: 25192907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices.
    Jennings DL; Chopra A; Chambers R; Morgan JA
    Artif Organs; 2014 Oct; 38(10):875-9. PubMed ID: 24571683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.